Giannobile W V, McDevitt J T, Niedbala R S, Malamud D
Department of Periodontics, Michigan Center for Oral Health Research, University of Michigan School of Dentistry, Ann Arbor, USA.
Adv Dent Res. 2011 Oct;23(4):375-80. doi: 10.1177/0022034511420434.
There have been significant advances in techniques for the detection of biomarker signals in the oral cavity (e.g., ELISAs for proteins, PCR for RNA and DNA) as well as the engineering and development of microfluidic approaches to make oral-based point-of-care (POC) methods for the diagnosis for both local and systemic conditions a reality. In this section, we focus on three such approaches, namely, periodontal disease management, early markers for systemic diseases, and salivary markers useful for pharmacogenomic studies. Novel approaches using non-invasive, salivary samples and user-friendly devices offer results that are as sensitive and specific as laboratory-based analyses using blood or urine.
口腔中生物标志物信号检测技术(例如蛋白质的酶联免疫吸附测定、RNA和DNA的聚合酶链反应)以及微流控方法的工程设计与开发取得了重大进展,使基于口腔的即时检测(POC)方法用于诊断局部和全身疾病成为现实。在本节中,我们重点介绍三种此类方法,即牙周疾病管理、全身性疾病的早期标志物以及对药物基因组学研究有用的唾液标志物。使用非侵入性唾液样本和用户友好型设备的新方法所提供的结果与使用血液或尿液的实验室分析一样灵敏和特异。